Mayte Pérez‐Olmeda

5.4k total citations
71 papers, 1.7k citations indexed

About

Mayte Pérez‐Olmeda is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mayte Pérez‐Olmeda has authored 71 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 27 papers in Virology and 27 papers in Epidemiology. Recurrent topics in Mayte Pérez‐Olmeda's work include HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (25 papers) and Hepatitis C virus research (18 papers). Mayte Pérez‐Olmeda is often cited by papers focused on HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (25 papers) and Hepatitis C virus research (18 papers). Mayte Pérez‐Olmeda collaborates with scholars based in Spain, United States and Portugal. Mayte Pérez‐Olmeda's co-authors include Vincent Soriano, José Alcamı́, Mayte Coiras, María Rosa López‐Huertas, Marina Núñez, Juan González‐Lahoz, Javier García‐Samaniego, Pilar Ríos, Bonaventura Clotet and Amalia Rubio and has published in prestigious journals such as Nature Reviews Microbiology, Journal of Virology and American Journal of Public Health.

In The Last Decade

Mayte Pérez‐Olmeda

69 papers receiving 1.7k citations

Peers

Mayte Pérez‐Olmeda
Gretja Schnell United States
John C. Tilton United States
E. Randall Lanier United States
Fiona Wightman Australia
Maria Prins Netherlands
John Delehanty United States
S. Alireza Rabi United States
Mayte Pérez‐Olmeda
Citations per year, relative to Mayte Pérez‐Olmeda Mayte Pérez‐Olmeda (= 1×) peers Valentina Svicher

Countries citing papers authored by Mayte Pérez‐Olmeda

Since Specialization
Citations

This map shows the geographic impact of Mayte Pérez‐Olmeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayte Pérez‐Olmeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayte Pérez‐Olmeda more than expected).

Fields of papers citing papers by Mayte Pérez‐Olmeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayte Pérez‐Olmeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayte Pérez‐Olmeda. The network helps show where Mayte Pérez‐Olmeda may publish in the future.

Co-authorship network of co-authors of Mayte Pérez‐Olmeda

This figure shows the co-authorship network connecting the top 25 collaborators of Mayte Pérez‐Olmeda. A scholar is included among the top collaborators of Mayte Pérez‐Olmeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayte Pérez‐Olmeda. Mayte Pérez‐Olmeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nasarre, Laura, Elena Mateos, Mayte Pérez‐Olmeda, et al.. (2024). Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus. Frontiers in Immunology. 15. 1362621–1362621. 1 indexed citations
2.
Rodríguez-Mora, Sara, Magdalena Corona, Elena Mateos, et al.. (2023). Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19. Cancers. 15(20). 5066–5066. 1 indexed citations
3.
García‐Pérez, Javier, Mercedes Bermejo, Erick De La Torre Tarazona, et al.. (2023). Longer intervals between SARS‐CoV‐2 infection and mRNA‐1273 doses improve the neutralization of different variants of concern. Journal of Medical Virology. 95(3). e28679–e28679. 3 indexed citations
4.
Valerio, Lluís, Sílvia Roure, Gema Fernández‐Rivas, et al.. (2023). Zika virus screening during pregnancy: Results and lessons learned from a screening program and a post‐delivery follow‐up analysis (2016–2022). Birth Defects Research. 115(17). 1646–1657. 1 indexed citations
5.
Rodríguez-Mora, Sara, Javier García‐Pérez, Magdalena Corona, et al.. (2022). Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection. Journal of Clinical Medicine. 11(8). 2137–2137. 2 indexed citations
6.
Torres, Montserrat, Magdalena Corona, Sara Rodríguez-Mora, et al.. (2022). Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster. Cancers. 14(22). 5537–5537. 1 indexed citations
7.
Rodríguez-Mora, Sara, Magdalena Corona, Montserrat Torres, et al.. (2022). Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19. Journal of Clinical Medicine. 11(10). 2803–2803. 5 indexed citations
8.
González‐Praetorius, Alejandro, et al.. (2022). Measles outbreak in the sanitary area of Guadalajara (Spain): difficulty in microbiological diagnosis in the era of its elimination. Enfermedades infecciosas y microbiologia clinica (English ed ). 40(10). 532–538. 3 indexed citations
9.
González-Pérez, María, María Montes‐Casado, Patricia Conde, et al.. (2022). Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination. Frontiers in Immunology. 13. 845882–845882. 5 indexed citations
10.
Pérez‐Olmeda, Mayte, José María Saugar, Aurora Fernández-García, et al.. (2022). Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in Spain. Journal of Clinical Virology. 149. 105130–105130. 9 indexed citations
11.
Fernández-García, Aurora, et al.. (2021). Measles in Vaccinated People: Epidemiology and Challenges in Surveillance and Diagnosis in the Post-Elimination Phase. Spain, 2014–2020. Viruses. 13(10). 1982–1982. 20 indexed citations
12.
García‐Pérez, Javier, Sara Rodríguez-Mora, Montserrat Torres, et al.. (2021). Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU. Frontiers in Immunology. 12. 742631–742631. 25 indexed citations
13.
Luna, Alejandro, Miguel Á. Galán, Sara Rodríguez-Mora, et al.. (2020). Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission. Journal of Clinical Medicine. 10(1). 42–42. 17 indexed citations
14.
Pérez‐Olmeda, Mayte, Juan Pedro M. Camacho, Jesús de la Fuente, et al.. (2020). Comparative evaluation of assays for IgM detection of rubella and measles infections. Enfermedades Infecciosas y Microbiología Clínica. 40(1). 22–27.
15.
Pérez‐Olmeda, Mayte & José Alcamı́. (2013). Determination of HIV tropism and its use in the clinical practice. Expert Review of Anti-infective Therapy. 11(12). 1291–1302. 8 indexed citations
16.
Gonzàlez, Núria, Mayte Pérez‐Olmeda, Elena Mateos, et al.. (2010). A sensitive phenotypic assay for the determination of human immunodeficiency virus type 1 tropism. Journal of Antimicrobial Chemotherapy. 65(12). 2493–2501. 33 indexed citations
17.
Coiras, Mayte, María Rosa López‐Huertas, Mayte Pérez‐Olmeda, & José Alcamı́. (2009). Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nature Reviews Microbiology. 7(11). 798–812. 223 indexed citations
18.
Romero, Míriam, Mayte Pérez‐Olmeda, Javier García‐Samaniego, & Vincent Soriano. (2004). Management of Chronic Hepatitis C in Patients Co-Infected with HIV. Drug Safety. 27(1). 7–24. 11 indexed citations
19.
Pérez‐Olmeda, Mayte, Vincent Soriano, Víctor Asensi, et al.. (2003). Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon α -2b Plus Ribavirin. AIDS Research and Human Retroviruses. 19(12). 1083–1089. 21 indexed citations
20.
Pérez‐Olmeda, Mayte, M. Hernández, Rafael Sirera, et al.. (1999). CCR5 Genotype and Human Immunodeficiency Virus Type 1 Infection in Perinatally Exposed Infants. European Journal of Clinical Microbiology & Infectious Diseases. 18(5). 389–391. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026